Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions.

Saved in:
Bibliographic Details
Title: Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions.
Authors: Arzika AM; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Amza A; Programme Nationale de Santé Oculaire, Ministère de la Santé Publique, Niamey, Niger., Ousmane S; Centre de Recherche Médicale et Sanitaire, Ministère de la Santé Publique, Niamey, Niger., Maliki R; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Almou I; Programme Nationale de Santé Oculaire, Ministère de la Santé Publique, Niamey, Niger., Galo N; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Harouna N; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Mankara A; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Aichatou B; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Boubacar O; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Lebas E; Francis I. Proctor Foundation, University of California, San Francisco, USA., Peterson B; Francis I. Proctor Foundation, University of California, San Francisco, USA., Brandt C; Francis I. Proctor Foundation, University of California, San Francisco, USA., Picariello A; Francis I. Proctor Foundation, University of California, San Francisco, USA., Cheng A; Francis I. Proctor Foundation, University of California, San Francisco, USA., Porco TC; Francis I. Proctor Foundation, University of California, San Francisco, USA.; Department of Ophthalmology, University of California, San Francisco, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA., Doan T; Francis I. Proctor Foundation, University of California, San Francisco, USA.; Department of Ophthalmology, University of California, San Francisco, USA., Arnold BF; Francis I. Proctor Foundation, University of California, San Francisco, USA.; Department of Ophthalmology, University of California, San Francisco, USA.; Institute for Global Health Sciences, University of California, San Francisco, USA., Lietman TM; Francis I. Proctor Foundation, University of California, San Francisco, USA.; Department of Ophthalmology, University of California, San Francisco, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.; Institute for Global Health Sciences, University of California, San Francisco, USA., O'Brien KS; Francis I. Proctor Foundation, University of California, San Francisco, USA. kieran.obrien@ucsf.edu.; Department of Ophthalmology, University of California, San Francisco, USA. kieran.obrien@ucsf.edu.; Department of Epidemiology and Biostatistics, University of California, San Francisco, USA. kieran.obrien@ucsf.edu.; Institute for Global Health Sciences, University of California, San Francisco, USA. kieran.obrien@ucsf.edu.
Source: Trials [Trials] 2026 Feb 18; Vol. 27 (1). Date of Electronic Publication: 2026 Feb 18.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1745-6215
DOI:10.1186/s13063-026-09561-2